Ted M. Dawson
20Patents
9h-index
28Co-inventors
75Inventor score
Filing activity: May 12, 1992 → Oct 26, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5798355A | Inhibitors of rotamase enzyme activity | Human Necessities | 75 | Expired |
| US5587384A | Inhibitors of poly(ADP-ribose) synthetase and use thereof to treat NMDA neurotoxicity | Human Necessities | 64 | Expired |
| US5266594A | Inhibitors of nitric oxide synthase and use thereof to prevent glutamate neurotoxicity | Human Necessities | 44 | Expired |
| US6358975B1 | Method of using selective parp inhibitors to prevent or treat neurotoxicity | Human Necessities | 35 | Expired |
| USRE36397E | Inhibitors of poly(ADP-ribose) synthetase and use thereof to treat NMDA neurotoxicity | General | 35 | Expired |
| US5843960A | Inhibitors of rotamase enzyme activity | Human Necessities | 21 | Expired |
| US5898029A | Direct influences on nerve growth of agents that interact with immunophilins in combination with neurotrophic factors | Human Necessities | 19 | Expired |
| US5846981A | Inhibitors of rotamase enzyme activity | Human Necessities | 19 | Expired |
| US6500843B2 | Inhibitors of rotamase enzyme activity | Human Necessities | 10 | Expired |
| US6080753A | Stimulating nerve growth with immunophilins | Human Necessities | 9 | Expired |
| US6022878A | Inhibitors of rotamase enzyme activity | Human Necessities | 4 | Expired |
| US6362160B1 | Immunophilin-binding agents prevent glutamate neurotoxicity associated with vascular stroke and neurodegenerative diseases | Human Necessities | 2 | Expired |
| US9309208B2 | Methods of making and using thioxothiazolidine and rhodanine derivatives as HIV-1 and JSP-1 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11123405B2 | Long-acting GLP-1R agonist as a therapy of neurological and neurodegenerative conditions | Human Necessities | 0 | Active |
| US9623039B2 | Treatment and prevention of pathological conditions using iduna related techniques and compositions | Chemistry; Metallurgy | 0 | Active |
| US8921042B2 | Transcriptional repression leading to Parkinson's disease | Physics | 0 | Active |
| US9274128B2 | Transcriptional repression leading to parkinson's disease | Physics | 0 | Active |
| US12276657B2 | Detection of PAR in the CSF of patients with Parkinson's disease | Physics | 0 | Active |
| US8603994B2 | Transcriptional repression leading to Parkinson's disease | Physics | 0 | Active |
| US12233109B2 | Long-acting GLP-1r agonist as a therapy of neurological and neurodegenerative conditions | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.